iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19. It has various advantages over injectable vaccines. Here are a few of them. ... Jan 17
DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India. ... Jan 04
... Dec 05
Unlike in active vaccination, passive vaccination involves the administration of ready-made antibodies, which are degraded after some time.... Sep 26
Oral Covid vaccine gains ground... Sep 18
According to the yet-to-be published findings, the vaccine combined with the Seqirus MF59 adjuvant, provided protection against virus reproduction in hamster models.... Aug 26
The research by the University of Hong Kong is amongst few of the first to specifically investigate whether masks can stop COVID-19 carriers from ... May 18
Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)... Feb 08
-Advertisements-
-23-300x250.png)
.jpeg)
Sunday, November 01, 2026
.jpg)
.jpg)
.jpg)
.jpg)